30
Participants
Start Date
January 11, 2019
Primary Completion Date
August 30, 2020
Study Completion Date
August 30, 2021
Rontis DCB
"The Rontis DCB is intended for use as a percutaneous transluminal angioplasty (PTA) catheter to dilate stenotic or obstructive vascular lesions in the lower extremities for the purpose of improving limb perfusion and decreasing the incidence of restenosis.~In this study, it is intended to use Rontis DCB for treatment of lesions in the femoropopliteal arteries"
251 Airforce General Hospital, Athens
University General Hospital Attikon, Athens
University General Hospital of Patras,, Pátrai
"General Hospital of Thessaloniki G. Gennimatas", Thessaloniki
Uniiversity Hospital of Larisa, Larissa
Collaborators (1)
Pharmassist Ltd
INDUSTRY
Rontis Hellas SA
INDUSTRY